No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
154 |
4. Check minimum number of eventsNone |
154 |
5. Include endpointsNone |
154 |
6. Filter based on genotype QC (FinnGen only) |
129 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEXUAL_TRANSMISSION
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Other and unspecified syphilis, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Infections with a predominantly sexual mode of transmission, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 129 | 31 | 98 |
| Unadjusted period prevalence (%) | 0.04 | 0.01 | 0.04 |
| Median age at first event (years) | 45.22 | 39.60 | 46.99 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 149
- Matched controls
- 1490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
126.8
103
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
32.1
98.0
77
48
WW200
NOMESCO Finland
Immunization
36.0
72.2
49
20
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
127.5
43.6
45
5
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
+∞
40.5
37
*
Y25
ICPC
Fear sexually transm disease male
13.1
35.1
38
38
A51.0
ICD-10 Finland
Primary genital syphilis
+∞
34.8
32
*
A53.0
ICD-10 Finland
Latent syphilis, unspecified as early or late
+∞
33.6
31
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
74.4
22.6
25
*
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
22.5
21
*
Z25.1
ICD-10 Finland
Need for immunization against influenza
10.3
21.3
26
30
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
7.0
20.3
36
65
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
20.3
19
*
A54.5
ICD-10 Finland
Gonococcal pharyngitis
229.2
20.1
20
*
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
+∞
19.2
18
*
Z3231
NOMESCO Finland
Registered nurse
4.6
19.0
71
245
Z2221
NOMESCO Finland
Medical doctor
4.5
17.7
64
214
Z71.8
ICD-10 Finland
Other specified counselling
4.2
16.8
80
324
Y70
ICPC
Syphilis male
+∞
15.9
15
*
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
26.9
15.6
21
9
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
82.6
13.8
15
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
+∞
13.8
13
*
09710
ICD-8 Finland
Other syphilis and not specified, Latent syphilis, unspecified
+∞
11.6
11
*
A63.0
ICD-10 Finland
Anogenital (venereal) warts
15.6
11.3
18
13
Z29.2
ICD-10 Finland
Other prophylactic chemotherapy
118.0
10.6
11
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
106.5
9.5
10
*
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
9.5
9
*
UJF30
NOMESCO Finland
Ileoscopy through colon
4.5
9.0
24
61
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.2
8.6
43
169
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
+∞
8.4
8
*
A52.9
ICD-10 Finland
Late syphilis, unspecified
+∞
8.4
8
*
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
+∞
8.4
8
*
TAB00
NOMESCO Finland
Lumbar puncture
6.6
8.0
20
34
WX110, ,
SPAT
4.7
8.0
20
48
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.7
7.5
57
278
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.7
7.5
54
257
J01MA02
ATC
ciprofloxacin; systemic
2.6
7.4
65
341
A53
ICD-10 Finland
Other and unspecified syphilis
+∞
7.3
7
*
Y71
ICPC
Gonorrhoea male
+∞
7.3
7
*
D01
ICPC
Abdominal pain/cramps general
3.3
6.6
27
93
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.7
6.5
41
181
S02.51
ICD-10 Finland
Fracture of tooth, open
3.8
6.4
21
62
ZX114
NOMESCO Finland
Intramuscular
11.8
6.4
11
10
A54.9
ICD-10 Finland
Gonococcal infection, unspecified
+∞
6.3
6
*
A52.2
ICD-10 Finland
Asymptomatic neurosyphilis
+∞
6.3
6
*
A52.3
ICD-10 Finland
Neurosyphilis, unspecified
+∞
6.3
6
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
6.3
6
*
Z2446
NOMESCO Finland
Social worker
4.1
6.0
17
45
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
48
13
54.00
80.13
19.5
10.5
817.14
65.60
u/ml
—
29
5
78
83
18.62
72.88
9.4
2.0
—
—
—
0
0
78
88
17.50
69.95
9.8
2.1
—
—
—
0
0
87
224
7.93
36.56
8.1
2.1
—
—
—
0
0
82
207
7.59
34.86
7.5
2.0
—
—
—
0
0
89
489
3.04
10.00
5.7
4.8
38.13
36.68
g/l
1.56
89
470
48
189
3.27
9.64
3.6
2.4
1.76
1.68
e6/l
0.03
13
87
110
707
3.12
8.85
14.8
11.5
3.64
4.22
e9/l
1.97
96
623
103
642
2.96
8.71
4.3
3.5
0.00
0.00
estimate
—
8
136
102
634
2.93
8.64
4.2
3.4
0.00
0.00
estimate
—
8
136
22
55
4.52
8.41
1.0
1.4
268.60
273.35
miu/ml
—
5
35
103
649
2.90
8.40
4.3
3.5
0.00
0.00
estimate
—
6
125
47
203
2.92
7.87
3.6
2.4
1.39
0.95
e6/l
0.40
12
102
16
25
7.03
6.85
1.1
1.1
11.11
3.76
e6/l
—
9
17
62
328
2.52
6.83
3.9
2.6
0.10
0.40
e6/l
2.32
41
234
21
60
3.91
6.72
1.8
1.4
—
—
—
0
0
16
26
6.76
6.68
1.1
1.2
65.11
376.33
e6/l
—
9
18
17
42
4.44
6.55
2.7
1.5
—
—
—
0
0
122
902
2.95
6.34
9.8
8.6
74.70
77.66
u/l
0.53
122
864
13
17
8.26
6.27
1.2
1.1
—
—
—
0
0
73
451
2.21
5.33
1.9
1.9
94.87
96.76
pmol/l
0.14
36
231
14
28
5.40
5.09
2.2
3.5
1.13
2.26
index
—
8
16
11
20
5.85
4.38
3.0
1.9
—
—
—
0
0
48
270
2.15
4.27
1.6
1.5
18.61
20.29
nmol/l
0.48
42
233
40
220
2.12
3.72
3.0
3.1
150.62
659.49
ng/l
0.58
29
161
6
6
10.35
3.53
1.0
1.2
—
—
—
0
0
38
209
2.10
3.52
1.8
1.9
2.58
2.91
mg/l
0.42
29
187
126
1058
2.24
3.22
27.2
17.1
13.30
13.40
%
0.38
126
1051
11
30
3.87
3.16
1.4
1.4
194.00
151.29
au/ml
—
5
7
8
17
4.91
2.96
1.3
1.1
—
—
—
0
0
46
293
1.82
2.73
1.5
1.3
0.79
1.18
u/ml
—
8
85
9
26
3.62
2.52
1.0
1.3
—
—
—
0
0
7
16
4.53
2.50
1.3
2.6
—
—
—
0
0
40
254
1.79
2.37
2.0
2.4
—
—
—
0
0
9
28
3.35
2.35
1.1
1.4
219.00
230.64
u/ml
—
9
11
8
24
3.46
2.21
1.6
1.4
—
—
—
0
0
6
14
4.42
2.17
1.0
1.1
—
—
—
0
0
18
92
2.09
2.00
1.7
3.5
65.67
74.35
ml/min/173m2
—
6
48
16
78
2.18
1.99
2.1
1.8
—
—
—
0
0
134
1208
2.09
1.99
20.7
13.1
89.58
88.85
ml/min/173m2
0.15
124
1102
136
1233
2.18
1.98
16.2
14.2
29.50
23.37
mg/l
1.20
114
1007
9
33
2.84
1.97
1.2
1.4
—
—
—
0
0
19
101
2.01
1.91
5.3
8.1
1.15
1.29
mmol/l
0.57
19
101
8
28
2.96
1.89
1.5
1.6
—
—
—
0
0
5
12
4.27
1.84
2.8
3.6
—
—
—
0
0
9
35
2.67
1.83
1.0
1.1
—
—
—
0
0
9
35
2.67
1.83
1.0
1.1
—
—
—
0
0
5
13
3.94
1.73
1.2
1.0
—
—
—
0
0
5
13
3.94
1.73
1.0
1.1
—
—
—
0
0
108
931
1.58
1.70
4.2
3.2
—
—
—
0
0
13
63
2.17
1.65
1.0
1.0
—
—
—
0
0
13
65
2.10
1.54
1.5
1.3
—
—
—
0
0
6
21
2.93
1.52
1.5
1.4
—
—
—
0
0
6
21
2.93
1.52
1.5
1.4
—
—
—
0
0
38
270
1.55
1.44
2.3
1.6
—
—
—
0
0
30
422
0.64
1.38
3.6
3.8
24.56
21.93
%
0.32
15
156
17
98
1.83
1.38
2.0
2.5
0.26
0.23
g/l
0.92
17
89
64
512
1.44
1.35
2.6
2.8
—
—
estimate
—
0
0
13
70
1.94
1.28
5.0
2.6
22.05
24.48
mmol/l
1.87
13
70
14
78
1.88
1.26
1.2
1.2
87.11
373.79
u/ml
0.76
14
68
12
65
1.92
1.17
9.8
3.9
154.33
86.50
ng/l
0.65
12
60
127
1171
1.57
1.14
6.9
4.4
5.98
5.92
mmol/l
0.15
122
1092
97
860
1.37
1.01
3.5
3.6
14.25
14.72
pmol/l
1.06
91
793
35
451
0.71
0.99
3.2
3.2
32.01
40.81
ng/l
0.25
20
292
140
1338
1.77
0.95
25.2
17.1
86.51
79.44
umol/l
0.54
140
1326
11
63
1.81
0.93
1.3
1.2
—
—
—
0
0
6
34
1.80
0.77
1.0
3.4
26.67
52.76
u/ml
—
6
34
44
359
1.32
0.77
4.6
4.0
8.99
6.47
mg/mmol
0.14
31
236
36
285
1.35
0.77
2.9
3.7
1.01
1.02
kg/l
1.66
26
186
5
24
2.12
0.75
1.0
1.6
—
—
—
0
0
5
24
2.12
0.75
1.0
1.1
—
—
—
0
0
5
92
0.53
0.69
1.4
1.5
—
—
—
0
0
5
28
1.81
0.67
1.0
1.5
—
—
—
0
0
5
29
1.75
0.64
1.6
1.3
—
—
—
0
0
19
140
1.41
0.62
1.8
1.8
—
—
—
0
0
134
1284
1.43
0.61
7.9
5.1
2.75
2.82
mmol/l
0.46
128
1214
19
142
1.39
0.58
1.8
1.7
—
—
—
0
0
9
60
1.53
0.55
2.1
1.8
—
—
—
0
0
9
61
1.51
0.55
2.4
2.3
1.40
1.45
%
—
9
61
7
45
1.58
0.49
1.3
2.4
—
—
—
0
0
5
32
1.58
0.42
2.0
1.5
1274.08
856.86
mu/l
—
5
24
0
15
0.00
0.41
0.0
2.6
—
15.79
—
0
15
0
15
0.00
0.41
0.0
1.1
—
2.15
—
0
15
17
214
0.77
0.41
1.2
1.2
40.80
25.00
iu/ml
—
7
54
142
1389
1.47
0.41
29.4
21.3
42.23
42.29
%
0.06
142
1379
142
1389
1.47
0.41
29.1
21.1
142.07
142.37
g/l
0.09
142
1380
142
1389
1.47
0.41
28.9
20.9
90.97
90.25
fl
1.05
142
1381
0
17
0.00
0.41
0.0
1.5
—
13.12
—
0
17
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
20.57
—
0
10
0
19
0.00
0.39
0.0
2.2
—
—
—
0
0
5
36
1.40
0.38
1.0
1.5
—
—
—
0
0
5
79
0.62
0.36
1.0
1.7
—
—
—
0
0
126
1216
1.23
0.36
6.2
4.0
1.39
1.37
mmol/l
0.15
119
1147
28
325
0.83
0.34
3.1
2.6
0.62
0.71
ug/l
0.38
19
157
34
386
0.85
0.33
3.2
2.7
0.00
0.00
estimate
—
5
107
131
1272
1.25
0.33
7.5
4.7
4.48
4.66
mmol/l
1.54
125
1207
10
128
0.77
0.28
5.7
7.6
—
—
—
0
0
10
127
0.77
0.26
4.6
4.4
28.40
29.73
%
—
5
86
6
85
0.69
0.24
1.2
1.1
1.05
0.87
g/l
—
6
85
6
85
0.69
0.24
1.2
1.1
1.45
1.47
g/l
—
6
85
130
1269
1.19
0.24
7.6
4.6
1.29
1.35
mmol/l
1.23
124
1201
31
345
0.87
0.23
3.1
3.4
0.00
0.01
estimate
—
7
133
22
191
1.18
0.23
2.0
2.0
—
—
—
0
0
5
41
1.23
0.22
1.0
1.8
—
—
—
0
0
5
42
1.20
0.21
1.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
13.30
—
0
10
0
10
0.00
0.21
0.0
1.8
—
2.60
—
0
5
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
7
85
0.81
0.15
2.0
1.9
195.71
230.24
pmol/l
—
7
80
47
495
0.93
0.13
3.4
3.2
0.00
0.01
estimate
—
6
116
35
328
1.09
0.12
2.1
2.5
378.86
355.17
umol/l
0.90
35
288
5
46
1.09
0.09
1.6
1.5
5.96
23.07
iu/l
—
5
36
5
64
0.77
0.08
1.4
2.6
213.80
179.40
ng/l
—
5
56
19
181
1.06
0.03
1.2
1.3
1.21
8.07
u/ml
—
9
75
11
102
1.08
0.03
12.3
5.8
9.77
8.78
mmol/l
0.20
11
96
10
106
0.94
0.01
1.8
1.4
—
—
—
0
0
12
114
1.06
0.01
5.6
3.1
—
—
—
0
0
26
262
0.99
0.00
2.2
1.7
0.96
1.06
mg/l
0.13
18
202
0
7
0.00
-0.00
0.0
1.3
—
10.07
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.2
—
—
—
0
0
8
87
0.92
-0.00
1.3
2.2
6.16
6.21
ug/l
—
8
80
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
67.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
266.14
—
0
7
0
8
0.00
-0.00
0.0
1.4
—
198.88
—
0
8
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
43.93
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
36.66
—
0
8
0
5
0.00
-0.00
0.0
7.0
—
46.40
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
8.14
—
0
5
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
48.00
—
0
7
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
54.02
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
6.96
—
0
5
0
9
0.00
-0.00
0.0
7.2
—
134.56
—
0
9
0
6
0.00
-0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
392.75
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_SYPHILIS_NOS_WIDE – Other and unspecified syphilis, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).